Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-10

Clinical Trial Update: A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the usability of the Needle-free Intraject system in adults during an acute migraine attack has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Needle-free Intraject System

Snippet

Sponsor: Zogenix, Inc. | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED